FDA approves XFG-adapted COVID-19 vaccine - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA approves XFG-adapted COVID-19 vaccine

The 2026 to 2027 formulation aligns with FDA guidance on the preferred composition for COVID-19 vaccines beginning this fall.

  • By

  • Kathryn Wighton

  • August 28, 2026

  • 2 min

Share

Original Source(s)

FDA approves XFG-adapted COVID-19 vaccine

  • by Kathryn Wighton

  • August 28, 2026

Related Content

Epidemiological and genomic surveillance of influenza virus A, RSV B and SARS-CoV-2 in Bangladesh (2022-2024)

Case Report: Mitochondrial insufficiency underlies cholinergic failure in post-vaccination long COVID: a candidate treatment protocol

Immunization Awareness Month: How RTs Help Protect Patients